Association of factor V gene polymorphism with arteriovenous graft failure

American Journal of Kidney Diseases

Volumn 59, Issue 5, 2012, Pages 682-688

  Allon, Michael ^a   Zhang, Li ^b   Maya, Ivan D ^a   Bray, Molly S ^c   Fernandez, Jose R ^c  

^a University of Alabama at Birmingham   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Arteriovenous access; arteriovenous graft; genetic polymorphism; thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE; DIPYRIDAMOLE; HEME OXYGENASE 1; KLOTHO PROTEIN; NITRIC OXIDE SYNTHASE; PLACEBO; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANGIOPLASTY; ARTICLE; BLOOD VESSEL GRAFT; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE INTERACTION; GRAFT FAILURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; STENOSIS; THROMBOSIS;

ADULT; AGED; ASPIRIN; CHRONIC DISEASE; DIPYRIDAMOLE; DNA; DOUBLE-BLIND METHOD; FACTOR V; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PHARMACOGENETICS; PLATELET AGGREGATION INHIBITORS; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; VASCULAR GRAFTING;

EID: 84862803699     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.11.036     Document Type: Article

References (22)

1. Allon M. Current management of vascular access. Clin J Am Soc Nephrol. 2007;2:786-800.
2. Roy-Chaudhury P, Kelly BS, Miller MA, et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59:2325-2334. (Pubitemid 32467627)
3. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006;17:1112-1127.
4. Roy-Chaudhury P, Arend L, Zhang J, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50:782-790. (Pubitemid 47588553)
5. Chang CJ, Ko PJ, Hsu LA, et al. Highly increased cell proliferation activity in restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of stenosis. Am J Kidney Dis. 2004;43:74-84.
6. Girndt M, Heine GH, Ulrich C, Kohler H. Gene polymorphism association studies in dialysis: vascular access. Semin Dial. 2007;20:63-67.
7. Fukasawa M, Matsushita K, Kamiyama M, et al. The methylenetetrahydrofolate C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis. 2003;41:637-642. (Pubitemid 36278381)
8. Lin CC, Yang WC, Lin SJ, et al. Length polymorphism in heme-oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int. 2006;69:165-172.
9. Knoll GA, Wells PS, Young D, et al. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol. 2005;16:1108-1114. (Pubitemid 41710322)
10. Heine GH, Ulrich C, Sester U, Sester M, Kohler H, Girndt M. Transforming growth factor b1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int. 2003;64:1101-1107. (Pubitemid 37013849)
11. Lazo-Langner A, Knoll GA, Wells PS, Carson N, Rodger MA. The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene. Blood. 2006;108:4052-4058. (Pubitemid 44913274)
12. Kim Y, Jeong SJ, Lee HS, et al. Polymorphism in the promoter region of the klotho gene (G-395A) is associated with early dysfunction in vascular access in hemodialysis patients. Korean J Intern Med. 2008;23:201-207.
13. Heine GH, Ulrich C, Kohler H, Girndt M. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake? Am J Nephrol. 2004;24:461-468. (Pubitemid 39279390)
14. Petrovic D, Peterlin B. Genetic markers of restenosis after coronary angioplasty and after stent implantation. Med Sci Monit. 2005;11:127-135.
15. Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009;360:2191-2201.
16. Klimentidis YC, Divers J, Casazza K, Beasley TM, Allison DB, Fernandez JR. Ancestry informative markers on chromosomes 2, 8, and 15 are associated with insulin-related traits in a racially diverse sample of children. Hum Genomics. 2011;5:79-89.
17. Hanis CL, Chakraborty R, Ferrell RE, Schull WJ. Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. Am J Phys Anthropol. 1986;70:433-441. (Pubitemid 16041403)
18. Bejamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289-300.
19. Rayner HC, Pisoni Rl, Gillespie BW, et al. Creation, cannulation, and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003;63:323-330.
20. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67. (Pubitemid 24144355)
21. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
22. Wattanakit K, Cushman M, Stehman-Breen CO, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19:135-140.